Management of acute HVE infection in a patient treated with rituximab for rheumatoid arthritis
Conclusion This case highlights the safety and the efficacy of the reintroduction of rituximab after 2 months of treatment with ribavirin and a negative PCR.
Source: Joint Bone Spine - Category: Orthopaedics Source Type: research
More News: Arthritis | Hepatitis | Hospital Management | Jaundice | Men | Orthopaedics | Rheumatoid Arthritis | Rheumatology | Rituxan